Triple-Negative Breast Cancer Mutations in African American Women
- A new study in Nature genetics provides the most comprehensive genomic profile of triple-negative breast cancer (TNBC) in African American women, challenging previous assumptions and revealing a...
- Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2...
- TNBC disproportionately affects African American women, who are diagnosed at a younger age and have a higher mortality rate compared to women of other racial groups.
“`html
Landmark Study Reveals Genetic Landscape of Triple-Negative Breast Cancer in african American Women
Table of Contents
A new study in Nature genetics provides the most comprehensive genomic profile of triple-negative breast cancer (TNBC) in African American women, challenging previous assumptions and revealing a high prevalence of TP53 mutations.
What is Triple-Negative Breast Cancer?
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This makes it more difficult to treat because common hormone therapies and HER2-targeted drugs are ineffective. According to the National Cancer Institute, TNBC accounts for about 15-20% of all breast cancers.
The Disparity in TNBC Incidence
TNBC disproportionately affects African American women, who are diagnosed at a younger age and have a higher mortality rate compared to women of other racial groups. The Centers for Disease Control and prevention reports that African American women are more likely to die from breast cancer than White women. However, until now, they have been significantly underrepresented in genomic studies investigating the underlying causes of this disparity.
Key Findings of the Study
Researchers led by Song Yao, MD, phd, of Roswell Park Comprehensive Cancer Center, conducted whole-exome and RNA sequencing on samples from 462 African American women with TNBC. The study, “Mutational Landscape of Triple-Negative breast Cancer in African American Women”, published in Nature Genetics, revealed several key insights:
- Similar Mutational Profile: The overall mutational landscape of TNBC in African American women was largely similar to that of Asian American and non-Hispanic white women, with no evidence of association with African ancestry.
- High TP53 Mutation Rate: Mutations in the TP53 gene were found in nearly all (approximately 90%) of the African American TNBC patients studied – a significantly higher prevalence than previously reported.
- Other Frequent Mutations: Other frequently mutated genes included PIK3CA, GATA3, and NF1.
The researchers emphasize that the high frequency of TP53 mutations suggests this gene might potentially be a critical therapeutic target for African American women with TNBC.
Understanding the Role of TP53
TP53 is a tumor suppressor gene often referred to as the “guardian of the genome.” It plays a crucial role in preventing cancer growth by regulating cell growth, DNA repair, and programmed cell death (apoptosis). Mutations in TP53 can disable these functions, allowing cancer cells to grow and proliferate unchecked. According to the National Cancer Institute, TP53 is the most frequently mutated gene in human cancers.